Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes.

To find out more go to https://breakthrought1d.org.au/news/tzield-approved-in-australia/